Package 72888-462-02

{"route": ["ORAL"], "spl_id": "49fe26b4-1dcb-832f-e063-6294a90a6195", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0372888461014", "0372888460017", "0372888462011", "0372888460024", "0372888462028", "0372888461021"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["ab4c1f36-82fa-40a2-a31a-227875d0f382"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Advagen Pharma Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (72888-462-01)", "package_ndc": "72888-462-01", "marketing_start_date": "20250520"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (72888-462-02)", "package_ndc": "72888-462-02", "marketing_start_date": "20250520"}], "brand_name": "Oxcarbazepine", "product_id": "72888-462_49fe26b4-1dcb-832f-e063-6294a90a6195", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72888-462", "generic_name": "Oxcarbazepine", "labeler_name": "Advagen Pharma Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA207717", "marketing_category": "ANDA", "marketing_start_date": "20250520", "listing_expiration_date": "20271231"}